C09BA02 - Enalapril and Diuretics |
Probably not porphyrinogenic |
PNP |
Rationale
Enalapril: No evidence of CYP-dependent metabolism. Some clinical experience as well as two references point to non- porphyrinogenicity. Hydrochlorothiazide: Not metabolised. Probably no CYP-affinity. Clinical experience of non-porphyrinogenicity. Conflicting evidence.
Chemical description
Enalapril: ACE-inhibitor. Hydrolyzed to enalaprilate, otherwise not metabolized. Hydrochlorthiazide: Thiazide diuretic. Eliminated in urine in unchanged form. No observations of CYP interaction.
Personal communication
Enalapril:
Andersson, patient report (n=7) tolerated.
Hydrochlorthiazide:
Thunell, patient report (n=1): tolerated.
Andersson, patient reports (n=10): tolerated.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Drug reference publications | ||
| 1. | Martindale: The complete drug reference. Pharmaceutical Press.
Sweetman SC, editor.
|
|
| Porphyria Drug Lists | ||
| 2. | Australian List
Australian Porphyria Association No longer maintained
|
|
| 3. | French List
Centre Français des Porphyries
|
|
| 4. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames